The effects of estrogen on pulmonary artery vasoreactivity and hypoxic pulmonary vasoconstriction: Potential new clinical implications for an old hormone

Critical Care Medicine

Volumn 36, Issue 7, 2008, Pages 2174-2183

  Lahm, Tim ^a   Crisostomo, Paul R ^a   Markel, Troy A ^a   Wang, Meijing ^a   Weil, Brent R ^a   Novotny, Nathan M ^a   Meldrum, Daniel R ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Estradiol; Lung injury; Nongenomic effects; Pulmonary hypertension; Sex hormones; Shock

Indexed keywords

ENDOTHELIN 1; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; HYPERTENSIVE FACTOR; NITRIC OXIDE; PROSTACYCLIN;

ACUTE LUNG INJURY; ANTIINFLAMMATORY ACTIVITY; BLOOD VESSEL REACTIVITY; DRUG EFFECT; DRUG MECHANISM; ESTROGEN METABOLISM; ESTROGEN SYNTHESIS; HEART SURGERY; HUMAN; HYPERTENSIVE CRISIS; HYPOXIA; ISCHEMIA; LUNG BLOOD VESSEL; LUNG VASOCONSTRICTION; MEDLINE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; REPERFUSION INJURY; REVIEW; SEPSIS; SEX DIFFERENCE; SHOCK; SIGNAL TRANSDUCTION; VASODILATATION; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; FEMALE; MALE; METABOLISM; PHYSIOLOGY; VASOCONSTRICTION;

ANIMALS; DISEASE MODELS, ANIMAL; ESTRADIOL; ESTROGENS; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; RESPIRATORY DISTRESS SYNDROME, ADULT; VASOCONSTRICTION;

EID: 47249115325     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31817d1a92     Document Type: Review

References (142)

1. Payne AH, Hales DB: Overview of steroido-genic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev 2004; 25:947-970
2. Carey MA, Card JW, Voltz JW, et al: The impact of sex and sex hormones on lung physiology and disease: Lessons from animal studies. Am J Physiol Lung Cell Mol Physiol 2007; 293:L272-278
3. Mendelsohn ME, Karas RH: Molecular and cellular basis of cardiovascular gender differences. Science 2005; 308:1583-1587
4. Dubey RK, Jackson EK: Cardiovascular protective effects of 17beta-estradiol metabolites. J Appl Physiol 2001; 91:1868-1883
5. Dubey RK, Jackson EK: Estrogen-induced cardiorenal protection: Potential cellular, biochemical, and molecular mechanisms. Am J Physiol Renal Physiol 2001; 280: F365-388
6. Zhu BT, Conney AH: Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 1998; 19: 1-27
7. Dubey RK, Tofovic SP, Jackson EK: Cardiovascular pharmacology of estradiol metabolites. J Pharmacol Exp Ther 2004; 308: 403-409
8. Zacharia LC, Gogos JA, Karayiorgou M, et al: Methoxyestradiols mediate the antimito-genic effects of 17beta-estradiol: Direct evidence from catechol-O-methyltransferase-knockout mice. Circulation 2003; 108: 2974-2978
9. Crisostomo PR, Wang M, Herring CM, et al: Gender differences in injury induced mes-enchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: role of the 55 kDa TNF receptor (TNFR1). J Mol Cell Cardiol 2007; 42:142-149
10. Crisostomo PR, Wang M, Herring CM, et al: Sex dimorphisms in activated mesenchymal stem cell function. Shock 2006; 26:571-574
11. Choudhry MA, Bland KI, Chaudry IH: Gender and susceptibility to sepsis following trauma. Endocr Metab Immune Disord Drug Targets 2006; 6:127-135
12. Choudhry MA, Schwacha MG, Hubbard WJ, et al: Gender differences in acute response to trauma- hemorrhage. Shock 2005; 24(Suppl 1):101-106
13. Chaudry IH, Samy TS, Schwacha MG, et al: Endocrine targets in experimental shock. J Trauma 2003; 54(Suppl):S118-125
14. Meldrum DR: G-protein-coupled receptor 30 mediates estrogen's nongenomic effects after hemorrhagic shock and trauma. Am J Pathol 2007; 170:1148-1151
15. Karas RH, Patterson BL, Mendelsohn ME: Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 1994; 89:1943-1950
16. Venkov CD, Rankin AB, Vaughan DE: Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. Circulation 1996; 94:727-733
17. Couse JF, Lindzey J, Grandien K, et al: Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology 1997; 138:4613-4621
18. Deitch EA, Livingston DH, Lavery RF, et al: Hormonally active women tolerate shock-trauma better than do men: A prospective study of over 4000 trauma patients. Ann Surg 2007; 246:447- 453; discussion 453-445
19. Deitch EA, Feketeova E, Lu Q, et al: Resistance of the female, as opposed to the male, intestine to I/R-mediated injury is associated with increased resistance to gut-induced distant organ injury. Shock 2008; 29:78-83
20. Homma H, Hoy E, Xu DZ, et al: The female intestine is more resistant than the male intestine to gut injury and inflammation when subjected to conditions associated with shock states. Am J Physiol Gastroin-test Liver Physiol 2005; 288:G466-472
21. Cristofaro PA, Opal SM, Palardy JE, et al: WAY-202196, a selective estrogen receptor-beta agonist, protects against death in experimental septic shock. Crit Care Med 2006; 34:2188-2193
22. Yu HP, Hsieh YC, Suzuki T, et al: Mechanism of the nongenomic effects of estrogen on intestinal myeloperoxidase activity following trauma-hemorrhage: Up-regulation of the PI-3K/Akt pathway. J Leukoc Biol 2007; 82:774-780
23. Hsu JT, Kan WH, Hsieh CH, et al: Mechanism of estrogen-mediated attenuation of hepatic injury following trauma-hemorrhage: Akt-dependent HO-1 up-regulation. J Leukoc Biol 2007; 82:1019-1026
24. Hsieh YC, Yu HP, Frink M, et al: G protein-coupled receptor 30-dependent protein ki-nase A pathway is critical in nongenomic effects of estrogen in attenuating liver injury after trauma- hemorrhage. Am J Pathol 2007; 170:1210-1218
25. Hsieh YC, Frink M, Thobe BM, et al: 17Beta-estradiol downregulates Kupffer cell TLR4-dependent p38 MAPK pathway and normalizes inflammatory cytokine production following trauma-hemorrhage. Mol Immunol 2007; 44:2165-2172
26. Kawasaki T, Choudhry MA, Suzuki T, et al: 17beta-estradiol's salutary effects on splenic dendritic cell functions following trauma- hemorrhage are mediated via estrogen receptor-alpha. Mol Immunol 2008; 45:376-385
27. Suzuki T, Shimizu T, Yu HP, et al: Salutary effects of 17beta-estradiol on T-cell signaling and cytokine production after trauma- hemorrhage are mediated primarily via estrogen receptor-{alpha}. Am J Physiol Cell Physiol 2007; 292:C2103-2111
28. Angele MK, Frantz MC, Chaudry IH: Gender and sex hormones influence the response to trauma and sepsis: potential therapeutic approaches. Clinics 2006; 61:479-488
29. Hsieh YC, Frink M, Choudhry MA, et al: Metabolic modulators following trauma sepsis: sex hormones. Crit Care Med 2007; 35(Suppl):S621-629
30. Thawornkaiwong A, Preawnim S, Wattana-permpool J: Upregulation of beta 1-adren-ergic receptors in ovariectomized rat hearts. Life Sci 2003; 72:1813-1824
31. Kam KW, Qi JS, Chen M, et al: Estrogen reduces cardiac injury and expression of beta1-adrenoceptor upon ischemic insult in the rat heart. J Pharmacol Exp Ther 2004; 309:8-15
32. Wang M, Crisostomo P, Wairiuko GM, et al: Estrogen receptor-alpha mediates acute myocardial protection in females. Am J Physiol Heart Circ Physiol 2006; 290: H2204-2209
33. Wang M, Tsai BM, Crisostomo PR, et al: Tumor necrosis factor receptor 1 signaling resistance in the female myocardium dur- ing ischemia. Circulation 2006; 114(Suppl): I282-289
34. Wang M, Tsai BM, Kher A, et al: Role of endogenous testosterone in myocardial proinflammatory and proapoptotic signaling after acute ischemia-reperfusion. Am J Physiol Heart Circ Physiol 2005; 288: H221-226
35. Wang M, Baker L, Tsai BM, et al: Sex differences in the myocardial inflammatory response to ischemia-reperfusion injury. Am J Physiol Endocrinol Metab 2005; 288: E321-326
36. Murphy E, Steenbergen C: Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury. Cardiovasc Res 2007; 75:478-486
37. Murphy E, Steenbergen C: Cardioprotection in females: a role for nitric oxide and altered gene expression. Heart Fail Rev 2007; 12: 293-300
38. Wang M, Tsai BM, Reiger KM, et al: 17-beta-estradiol decreases p38 MAPK-mediated myocardial inflammation and dysfunction following acute ischemia. J Mol Cell Cardiol 2006; 40:205-212
39. Zhai P, Eurell TE, Cotthaus R, et al: Effect of estrogen on global myocardial ischemia-reperfusion injury in female rats. Am J Physiol Heart Circ Physiol 2000; 279: H2766-2775
40. Anderson SE, Kirkland DM, Beyschau A, et al: Acute effects of 17beta-estradiol on myocardial pH, Na+, and Ca2+ and ischemia-reperfusion injury. Am J Physiol Cell Physiol 2005; 288:C57-64
41. Szalay L, Shimizu T, Suzuki T, et al: Estradiol improves cardiac and hepatic function after trauma-hemorrhage: Role of enhanced heat shock protein expression. Am J Physiol Regul Integr Comp Physiol 2006; 290:R812-818
42. Lee TM, Chou TF, Tsai CH: Differential role of K(ATP) channels activated by conjugated estrogens in the regulation of myocardial and coronary protective effects. Circulation 2003; 107:49-54
43. Beer S, Reincke M, Kral M, et al: Susceptibility to cardiac ischemia/reperfusion injury is modulated by chronic estrogen status. J Cardiovasc Pharmacol 2002; 40:420-428
44. Sun J, Picht E, Ginsburg KS, et al: Hyper-contractile female hearts exhibit increased S-nitrosylation of the L-type Ca2+ channel alpha1 subunit and reduced ischemia/ reperfusion injury. Circ Res 2006; 98: 403-411
45. Gabel SA, Walker VR, London RE, et al: Estrogen receptor beta mediates gender differences in ischemia/reperfusion injury. J Mol Cell Cardiol 2005; 38:289-297
46. Nikolic I, Liu D, Bell JA, et al: Treatment with an estrogen receptor-beta-selective agonist is cardioprotective. J Mol Cell Cardiol 2007; 42:769-780
47. Booth EA Obeid NR, Lucchesi BR: Activation of estrogen receptor-alpha protects the in vivo rabbit heart from ischemia-reperfusion in- jury. Am J Physiol Heart Circ Physiol 2005; 289:H2039-2047
48. Crisostomo PR, Markel TA, Wang M, et al: In the adult mesenchymal stem cell population, source gender is a biologically relevant aspect of protective power. Surgery 2007; 142:215-221
49. Caruso JM, Deitch EA, Xu DZ, et al: Gut injury and gut-induced lung injury after trauma hemorrhagic shock is gender and estrus cycle specific in the rat. J Trauma 2003; 55:531-539
50. Ananthakrishnan P, Cohen DB, Xu DZ, et al: Sex hormones modulate distant organ injury in both a trauma/hemorrhagic shock model and a burn model. Surgery 2005; 137:56-65
51. Yu HP, Hsieh YC, Suzuki T, et al: Salutary effects of estrogen receptor-beta agonist on lung injury after trauma- hemorrhage. Am J Physiol Lung Cell Mol Physiol 2006; 290:L1004-1009
52. Toth B, Schwacha MG, Kuebler JF, et al: Gender dimorphism in neutrophil priming and activation following trauma-hemorrhagic shock. Int J Mol Med 2003; 11:357-364
53. Speyer CL, Rancilio NJ, McClintock SD, et al: Regulatory effects of estrogen on acute lung inflammation in mice. Am J Physiol Cell Physiol 2005; 288:C881-890
54. Rubenfeld GD, Caldwell E, Peabody E, et al: Incidence and outcomes of acute lung injury. N Engl J Med 2005; 353:1685-1693
55. Wanecek M, Oldner A, Rudehill A, et al: Endothelin(A)-receptor antagonism attenuates pulmonary hypertension in porcine en-dotoxin shock. Eur Respir J 1999; 13: 145-151
56. Tsai BM, Wang M, Pitcher JM, et al: Endo-thelium-dependent pulmonary artery va-sorelaxation is dysfunctional in males but not females after acute lung injury. Surgery 2005; 138:78-84
57. Rabinovitch M, Gamble WJ, Miettinen OS, et al: Age and sex influence on pulmonary hypertension of chronic hypoxia and on recovery. Am J Physiol 1981; 240:H62-72
58. Burton RR, Besch EL, Smith AH: Effect of chronic hypoxia on the pulmonary arterial blood pressure of the chicken. Am J Physiol 1968; 214:1438-1442
59. McMurtry IF, Frith CH, Will DH: Cardiopul-monary responses of male and female swine to simulated high altitude. J Appl Physiol 1973; 35:459-462
60. Resta TC, Kanagy NL, Walker BR: Estradiol-induced attenuation of pulmonary hypertension is not associated with altered eNOS expression. Am J Physiol Lung Cell Mol Physiol 2001; 280:L88-97
61. Stupfel M, Pesce VH, Gourlet V, et al: Sex-related factors in acute hypoxia survival in one strain of mice. Aviat Space Environ Med 1984; 55:136-140
62. Tofovic SP, Zhang X, Jackson EK, et al: 2-methoxyestradiol mediates the protective effects of estradiol in monocrotaline- induced pulmonary hypertension. Vascul Pharmacol 2006; 45:358-367
63. Zhang X, Jones T, Jackson EK, et al: 2-methoxyestradiol attenuates the development and retards the progression of chronic hypoxia-induced pulmonary hypertension in rats [Abstract]. Circulation 2005; 112: II98-II99
64. Lahm T, Patel KM, Crisostomo PR, et al: Endogenous estrogen attenuates pulmonary artery vasoreactivity and acute hypoxic pulmonary vasoconstriction: The effects of sex and menstrual cycle. Am J Physiol Endocrinol Metab 2007; 293:E865-871
65. English KM, Jones RD, Jones TH, et al: Gender differences in the vasomotor effects of different steroid hormones in rat pulmonary and coronary arteries. Horm Metab Res 2001; 33:645-652
66. Moore LG, Reeves JT: Pregnancy blunts pulmonary vascular reactivity in dogs. Am J Physiol 1980; 239:H297-301
67. Fuchs KI, Moore LG, Rounds S: Pulmonary vascular reactivity is blunted in pregnant rats. J Appl Physiol 1982; 53:703-707
68. Wetzel RC, Sylvester JT: Gender differences in hypoxic vascular response of isolated sheep lungs. J Appl Physiol 1983; 55: 100-104
69. Wetzel RC, Zacur HA, Sylvester JT: Effect of puberty and estradiol on hypoxic vasomotor response in isolated sheep lungs. J Appl Physiol 1984; 56:1199-1203
70. Sylvester JT, Gordon JB, Malamet RL, et al: Prostaglandins and estradiol-induced attenuation of hypoxic pulmonary vasoconstriction. Chest 1985; 88(Suppl):252S-254S
71. Turini P, Allemann Y, Sartori C, et al: Protective effects of female sex hormones against pulmonary hypertension in Bolivian high altitude natives [Abstract]. Circulation 2003; 111:B54
72. Hultgren HN, Lopez CE, Lundberg E, et al: Physiologic studies of pulmonary edema at high altitude. Circulation 1964; 29:393-408
73. Ergueta J, Spielvogel H, Cudkowicz L: Car-dio-respiratory studies in chronic mountain sickness (Monge's syndrome). Respiration 1971; 28:485-517
74. Scorza R, Caronni M, Bazzi S, et al: Post-menopause is the main risk factor for developing isolated pulmonary hypertension in systemic sclerosis. Ann N Y Acad Sci 2002; 966:238-246
75. Beretta L, Caronni M, Origgi L, et al: Hormone replacement therapy may prevent the development of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Scand J Rheumatol 2006; 35:468-471
76. Dransfield MT, Washko GR, Foreman MG, et al: Gender differences in the severity of CT emphysema in COPD. Chest 2007; 132: 464-470
77. Sunyer J, Anto JM, McFarlane D, et al: Sex differences in mortality of people who visited emergency rooms for asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 851-856
78. Rubin LJ: Primary pulmonary hypertension. N Engl J Med 1997; 336:111-117
79. McLaughlin VV, McGoon MD: Pulmonary arterial hypertension. Circulation 2006; 114:1417-1431
80. Gaine SP, Rubin LJ: Primary pulmonary hypertension. Lancet 1998; 352:719-725
81. Morse JH, Horn EM, Barst RJ: Hormone replacement therapy: A possible risk factor in carriers of familial primary pulmonary hypertension. Chest 1999; 116:847
82. Masi AT: Pulmonary hypertension and oral contraceptive usage [Editorial]. Chest 1976; 69:451-453
83. Kauser K, Rubanyi GM: Potential cellular signaling mechanisms mediating upregula-tion of endothelial nitric oxide production by estrogen. J Vasc Res 1997; 34:229-236
84. Gonzales RJ, Kanagy NL: Endothelium-independent relaxation of vascular smooth muscle by 17beta-estradiol. J Cardiovasc Pharmacol Ther 1999; 4:227-234
85. Gonzales RJ, Walker BR, Kanagy NL: 17be-ta-estradiol increases nitric oxide-dependent dilation in rat pulmonary arteries and thoracic aorta. Am J Physiol Lung Cell Mol Physiol 2001; 280:L555-564
86. Gordon JB, Wetzel RC, McGeady ML, et al: Effects of indomethacin on estradiol-induced attenuation of hypoxic vasocon-striction in lamb lungs. J Appl Physiol 1986; 61:2116-2121
87. Lantin-Hermoso RL, Rosenfeld CR, Yuhanna IS, et al: Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. Am J Physiol 1997; 273:L119-126
88. Sherman TS, Chambliss KL, Gibson LL, et al: Estrogen acutely activates prostacyclin synthesis in ovine fetal pulmonary artery endothelium. Am J Respir Cell Mol Biol 2002; 26:610-616
89. Shaul PW: Rapid activation of endothelial nitric oxide synthase by estrogen. Steroids 1999; 64:28-34
90. MacRitchie AN, Jun SS, Chen Z, et al: Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium. Circ Res 1997; 81:355-362
91. Karamsetty MR, Klinger JR, Hill NS: Phy-toestrogens restore nitric oxide-mediated relaxation in isolated pulmonary arteries from chronically hypoxic rats. J Pharmacol Exp Ther 2001; 297:968-974
92. Mishra SK, Abbot SE, Choudhury Z, et al: Endothelium-dependent relaxation of rat aorta and main pulmonary artery by the phytoestrogens genistein and daidzein. Cardiovasc Res 2000; 46:539-546
93. Farhat MY, Abi-Younes S, Dingaan B, et al: Estradiol increases cyclic adenosine mono-phosphate in rat pulmonary vascular smooth muscle cells by a nongenomic mechanism. J Pharmacol Exp Ther 1996; 276:652-657
94. Earley S, Resta TC: Estradiol attenuates hy-poxia-induced pulmonary endothelin-1 gene expression. Am J Physiol Lung Cell Mol Physiol 2002; 283:L86-93
95. Humbert M, Sitbon O, Simonneau G: Treatment of pulmonary arterial hypertension. N Engl J Med 2004; 351:1425-1436
96. Morrell ED, Tsai BM, Crisostomo PR, et al: Therapeutic concepts for hypoxic pulmonary vasoconstriction involving ion regulation and the smooth muscle contractile apparatus. J Mol Cell Cardiol 2006; 40: 751-760
97. Morrell ED, Tsai BM, Crisostomo PR, et al: Experimental therapies for hypoxia-induced pulmonary hypertension during acute lung injury. Shock 2006; 25:214-226
98. Farhat MY, Abi-Younes S, Ramwell PW: Non-genomic effects of estrogen and the vessel wall. Biochem Pharmacol 1996; 51: 571-576
99. Lahm T, Crisostomo PR, Markel TA, et al: The critical role of vascular endothelial growth factor in pulmonary vascular remodeling after lung injury. Shock 2007; 28:4-14
100. Yu HP, Hsieh YC, Suzuki T, et al: The PI3K/ Akt pathway mediates the nongenomic car-dioprotective effects of estrogen following trauma-hemorrhage. Ann Surg 2007; 245: 971-977
101. Warner M, Gustafsson JA: Nongenomic effects of estrogen: Why all the uncertainty? Steroids 2006; 71:91-95
102. Wang M, Zhang W, Crisostomo P, et al: Endothelial STAT3 plays a critical role in generalized myocardial proinflammatory and proapoptotic signaling. Am J Physiol Heart Circ Physiol 2007; 293:H2101-2108
103. Shimokawa H, Takeshita A: Rho-kinase is an important therapeutic target in cardiovascular medicine. Arterioscler Thromb Vasc Biol 2005; 25:1767-1775
104. Nagaoka T, Fagan KA, Gebb SA, et al: Inhaled rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension. Am J Respir Crit Care Med 2005; 171:494-499
105. Nagaoka T, Morio Y, Casanova N, et al: Rho/rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats. Am J Physiol Lung Cell Mol Physiol 2004; 287:L665-672
106. Fagan KA, Oka M, Bauer NR, et al: Attenuation of acute hypoxic pulmonary vasocon-striction and hypoxic pulmonary hypertension in mice by inhibition of rho-kinase. Am J Physiol Lung Cell Mol Physiol 2004; 287:L656-664
107. Abe K, Tawara S, Oi K, et al: Long-term inhibition of rho-kinase ameliorates hy-poxia-induced pulmonary hypertension in mice. J Cardiovasc Pharmacol 2006; 48: 280-285
108. Abe K, Shimokawa H, Morikawa K, et al: Long-term treatment with a rho-kinase in- hibitor improves monocrotaline-induced fatal pulmonary hypertension in rats. Circ Res 2004; 94:385-393
109. Tsai BM, Wang M, Pitcher JM, et al: Hypoxic pulmonary vasoconstriction and pulmonary artery tissue cytokine expression are mediated by protein kinase C. Am J Physiol Lung Cell Mol Physiol 2004; 287:L1215-1219
110. Liu SF, Dewar A, Crawley DE, et al: Effect of tumor necrosis factor on hypoxic pulmonary vasoconstriction. J Appl Physiol 1992; 72:1044-1049
111. Ertel W, Morrison MH, Ayala A, et al: Hy-poxemia in the absence of blood loss or significant hypotension causes inflammatory cytokine release. Am J Physiol 1995; 269:R160-166
112. Ward JP, Knock GA, Snetkov VA, et al: Protein kinases in vascular smooth muscle tone-role in the pulmonary vasculature and hypoxic pulmonary vasoconstriction. Pharmacol Ther 2004; 104:207-231
113. Stevens T, Janssen PL, Tucker A: Acute and long-term TNF-alpha administration increases pulmonary vascular reactivity in isolated rat lungs. J Appl Physiol 1992; 73: 708-712
114. Morrell ED, Tsai BM, Wang M, et al: p38 mitogen-activated protein kinase mediates the sustained phase of hypoxic pulmonary vasoconstriction and plays a role in phase I vasodilation. J Surg Res 2006; 134:335-341
115. Stenmark KR, Fagan KA, Frid MG: Hypoxia-induced pulmonary vascular remodeling: Cellular and molecular mechanisms. Circ Res 2006; 99:675-691
116. Ihionkhan CE, Chambliss KL, Gibson LL, et al: Estrogen causes dynamic alterations in endothelial estrogen receptor expression. Circ Res 2002; 91:814-820
117. Tofovic SP, Salah EM, Mady HH, et al: Es-tradiol metabolites attenuate monocrotal-ine-induced pulmonary hypertension in rats. J Cardiovasc Pharmacol 2005; 46: 430-437
118. Dubey RK, Jackson EK, Keller PJ, et al: Estradiol metabolites inhibit endothelin synthesis by an estrogen receptor-independent mechanism. Hypertension 2001; 37: 640-644
119. Dubey RK, Tyurina YY, Tyurin VA, et al: Estrogen and tamoxifen metabolites protect smooth muscle cell membrane phospholip-ids against peroxidation and inhibit cell growth. Circ Res 1999; 84:229-239
120. Seeger H, Mueck AO, Lippert TH: Effect of estradiol metabolites on the susceptibility of low density lipoprotein to oxidation. Life Sci 1997; 61:865-868
121. Seeger H, Mueck AO, Lippert TH: Effect of estradiol metabolites on prostacyclin synthesis in human endothelial cell cultures. Life Sci 1999; 65:PL167-170
122. Merriam GR, MacLusky NJ, Picard MK, et al: Comparative properties of the catechol estrogens, I: Methylation by catechol-O-methyltransferase and binding to cytosol estrogen receptors. Steroids 1980; 36:1-11
123. Sweeney C, Liu G, Yiannoutsos C, et al: A phase II multicenter, randomized, double-blind, safety trial assessing the pharmaco-kinetics, pharmacodynamics, and efficacy of oral 2-methoxyestradiol capsules in hormone-refractory prostate cancer. Clin Cancer Res 2005; 11:6625-6633
124. Rossouw JE, Anderson GL, Prentice RL, et al: Risks and benefits of estrogen plus pro-gestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321-333
125. Hopkins RA, Bull C, Haworth SG, et al: Pulmonary hypertensive crises following surgery for congenital heart defects in young children. Eur J Cardiothorac Surg 1991; 5:628-634
126. Kimblad PO, Green K, Sjoberg T, et al: Prostanoid release after lung transplantation. J Heart Lung Transplant 1996; 15: 999-1004
127. Takeuchi M, Imanaka H, Tachibana K, et al: Recruitment maneuver and high positive end-expiratory pressure improve hypoxemia in patients after pulmonary thromboendar-terectomy for chronic pulmonary thrombo-embolism. Crit Care Med 2005; 33: 2010-2014
128. Kim NH, Rubin LJ: Management following pulmonary thromboendarterectomy: Experience versus evidence. Crit Care Med 2005; 33:2132-2133
129. Zamanian RT, Haddad F, Doyle RL, et al: Management strategies for patients with pulmonary hypertension in the intensive care unit. Crit Care Med 2007; 35: 2037-2050
130. Hill NS, Klinger JR: Pulmonary hypertension in the intensive care unit: critical role of the right ventricle. Crit Care Med 2007; 35:2210-2211
131. Morelli A, Teboul JL, Maggiore SM, et al: Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study. Crit Care Med 2006; 34:2287-2293
132. Song GY, Chung CS, Rhee RJ, et al: Loss of signal transducer and activator of transduction 4 or 6 signaling contributes to immune cell morbidity and mortality in sepsis. Intensive Care Med 2005; 31:1564-1569
133. Lomas-Neira J, Chung CS, Perl M, et al: Role of alveolar macrophage and migrating neutrophils in hemorrhage-induced priming for ALI subsequent to septic challenge. Am J Physiol 2006; 290:L51-58
134. Perl M, Chung CS, Garber M, et al: Contribution of anti-inflammatory/ immune suppressive processes to the pathology of sepsis. Front Biosci 2006; 11:272-299
135. Lomas-Niera JL, Perl M, Chung CS, et al: Shock and hemorrhage: An overview of animal models. Shock 2005; 24(Suppl 1): 33-39
136. Wang H, Bloom O, Zhang M, et al: HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285:248-251
137. Coopersmith CM, Stromberg PE, Dunne WM, et al: Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. JAMA 2002; 287:1716-1721
138. Wisnoski N, Chung CS, Chen Y, et al: The contribution of cd4+ cd25+ T-regulatory-cells to immune suppression in sepsis. Shock 2007; 27:251-257
139. Wesche DE, Lomas-Neira JL, Perl M, et al: Leukocyte apoptosis and its significance in sepsis and shock. J Leukoc Biol 2005; 78: 325-337
140. Schneider CP, Nickel EA, Samy TS, et al: The aromatase inhibitor, 4-hydroxyandro-stenedione, restores immune responses following trauma-hemorrhage in males and decreases mortality from subsequent sepsis. Shock 2000; 14:347-353
141. Yokoyama Y, Nimura Y, Nagino M, et al: Current understanding of gender dimorphism in hepatic pathophysiology. J Surg Res 2005; 128:147-156
142. Diodato MD, Knoferl MW, Schwacha MG, et al: Gender differences in the inflammatory response and survival following haemorrhage and subsequent sepsis. Cytokine 2001; 14:162-169